Chemours Financials
| CC Stock | MXN 408.90 0.00 0.00% |
Chemours |
Understanding current and past Chemours Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Chemours' financial statements are interrelated, with each one affecting the others. For example, an increase in Chemours' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Chemours' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of The Chemours. Check Chemours' Beneish M Score to see the likelihood of Chemours' management manipulating its earnings.
Chemours Stock Summary
Chemours competes with Cognizant Technology, FibraHotel, FIBRA Storage, DXC Technology, and Grupo Sports. The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware. Chemours operates under Specialty Chemicals classification in Mexico and is traded on Mexico Stock Exchange. It employs 7000 people.| Foreign Associate | USA |
| Instrument | Mexico Stock View All |
| Exchange | Mexican Exchange |
| Business Address | 1007 Market Street, |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Benchmark | Dow Jones Industrial |
| Website | www.chemours.com |
| Phone | 302 773 1000 |
| Currency | MXN - Mexican Peso |
You should never invest in Chemours without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Chemours Stock, because this is throwing your money away. Analyzing the key information contained in Chemours' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Chemours Key Financial Ratios
Chemours' financial ratios allow both analysts and investors to convert raw data from Chemours' financial statements into concise, actionable information that can be used to evaluate the performance of Chemours over time and compare it to other companies across industries.| Return On Equity | 0.53 | |||
| Return On Asset | 0.0653 | |||
| Beta | 1.88 | |||
| Z Score | 16.2 | |||
| Last Dividend Paid | 1.0 |
Chemours Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Chemours's current stock value. Our valuation model uses many indicators to compare Chemours value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chemours competition to find correlations between indicators driving Chemours's intrinsic value. More Info.The Chemours is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers reporting about 0.12 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for The Chemours is roughly 8.09 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Chemours by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Chemours' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Chemours Systematic Risk
Chemours' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Chemours volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Chemours correlated with the market. If Beta is less than 0 Chemours generally moves in the opposite direction as compared to the market. If Chemours Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Chemours is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Chemours is generally in the same direction as the market. If Beta > 1 Chemours moves generally in the same direction as, but more than the movement of the benchmark.
Chemours December 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Chemours help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of The Chemours. We use our internally-developed statistical techniques to arrive at the intrinsic value of The Chemours based on widely used predictive technical indicators. In general, we focus on analyzing Chemours Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Chemours's daily price indicators and compare them against related drivers.
| Information Ratio | 0.1526 | |||
| Maximum Drawdown | 6.96 |
Additional Tools for Chemours Stock Analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.